Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PD-1
Pharma
Junshi, Coherus move Loqtorzi closer to another approval
Junshi revealed that a phase 3 trial of Loqtorzi plus Avastin prolonged the survival of first-line patients with hepatocellular carcinoma.
Kevin Dunleavy
Jun 12, 2024 11:45am
Summit and Akeso deliver Keytruda-topping results in NSCLC
May 31, 2024 11:00am
Merck's Keytruda misses the mark in endometrial cancer study
May 9, 2024 10:55am
Merck's Keytruda improves survival in cervical cancer trial
Mar 15, 2024 11:31am
Checkpoint slapped with CRL for skin cancer hopeful cosibelimab
Dec 19, 2023 10:11am
Keytruda snags FDA nod for NSCLC treatment around surgery
Oct 16, 2023 6:24pm
